External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ADPD 2025
Roche and Genentech at

ADPD 2025

April 01 - April 05
Vienna, Austria / Virtual (Hybrid)
adpd.kenes.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
08:00 AM
Duration 15mins Vienna
Evaluating future IVD plasma p-Tau181 and ApoE4 immunoassays for rule out of amyloid pathology in a multi-center study reflective of routine clinical practice
Clara Quijano-Rubio
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Vienna
Digital Health Technology feature space optimized to detect disease progression in early Parkinson’s disease under stable symptomatic treatment
Stefan Lambrecht
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:00 PM
Duration 15mins Vienna
PADOVA: Topline results from a Phase IIb study of prasinezumab in early-stage Parkinson’s disease participants on stable symptomatic treatment
Tania Nikolcheva
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:15 PM
Duration 15mins Vienna
Methodological considerations supporting a time-to-event primary endpoint in the PADOVA study in early-stage Parkinson’s disease participants on stable symptomatic treatment
Nathalie Pross
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:20 PM
Duration 15mins Vienna
Trontinemab - from early preclinical groundwork to the clinical validation of the Brainshuttle TM Platform
Luka Kulic
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:35 PM
Duration 15mins Vienna
Interim biomarker results of trontinemab, a novel Brainshuttle TM antibody in development for the treatment of Alzheimer's disease
Greg Klein
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:35 PM
Duration 15mins Vienna
Discovery of blood-based biomarkers for the detection and monitoring of amyloid related imaging abnormalities (ARIA)
Derrek Hibar
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:25 AM
Duration 15mins Vienna
Impact of ARIA on cerbral volume changes with gantenerumab
Matteo Tonietto
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
10:55 AM
Duration 16mins Vienna
A PHASE 1B STUDY TO TEST THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SELNOFLAST IN EARLY-STAGE PARKINSON’S DISEASE: STUDY DESIGN AND BASELINE CHARACTERISTICS
Gennaro Pagano
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:10 PM
Duration 15mins Vienna
Two-year progression of walking and turning in daily life of early Parkinson’s disease participants: exploratory findings from the prasinezumab PASADENA study
Sara Pagnamenta
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:25 PM
Duration 15mins Vienna
Progression of remotely smartphone-collected voice impairments in early Parkinson’s disease: exploratory results from the PASADENA study of prasinezumab
Damian Kwasny
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.